Citius Oncology, Inc.
CTOR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001851484
No open-market purchases or sales by Citius Oncology, Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $9.20M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Citius Oncology, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 11 | 6 | −5 |
| Shares | 200.9K | 105.0K | −95.9K (−47.7%) |
| Value | $230.2K | $97.7K | −$132.5K (−57.6%) |
New holders (0)
Institutions that held Citius Oncology, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
None.
Sold out (5)
Institutions that held Citius Oncology, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| HRT Financial LP | 68,543 | $78.0K |
| Citadel Advisors LLC | 22,699 | $26.1K |
| XTX Topco Ltd | 21,095 | $24.3K |
| Renaissance Technologies LLC | 11,196 | $12.9K |
| Tower Research Capital LLC (TRC) | 41 | $47 |